A new feeding system for safer and faster delivery of nutrition in critically ill patients
A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location
This study is testing a new feeding system that helps make sure nutrition is delivered safely to patients in intensive care, especially older adults, by keeping track of feeding tubes to prevent them from getting misplaced.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Theranova, LLC NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10689817 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative enteral feeding system designed to improve the delivery of nutrition to patients in intensive care units. By continuously monitoring the position of feeding tubes, the system aims to reduce the risks associated with misplaced tubes, which can lead to serious complications. The approach involves advanced technology to ensure accurate placement and minimize the need for repeated x-rays, thereby enhancing patient safety and care efficiency. This could significantly benefit older adults who are often the most vulnerable in critical care settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are critically ill patients, particularly those aged 65 and older, who require enteral nutrition during their hospital stay.
Not a fit: Patients who do not require enteral nutrition or are not admitted to intensive care units may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective nutritional support for critically ill patients, potentially reducing hospital stays and improving recovery outcomes.
How similar studies have performed: Previous research has shown that improving feeding tube placement techniques can enhance patient safety and outcomes, indicating that this approach has the potential for success.
Where this research is happening
San Francisco, United States
- Theranova, LLC — San Francisco, United States (Active)
Researchers
- Principal investigator: Burnett, Daniel Rogers — Theranova, LLC
- Study coordinator: Burnett, Daniel Rogers
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.